Educated Patient® Multiple Myeloma Summit

Multiple Myeloma 101: An Incurable But ‘Very Treatable’ Disease

March 22nd 2021, 3:00pm

Article

Although a multiple myeloma diagnosis can be overwhelming for patients, an expert from the Massachusetts General Hospital Cancer Center notes how the disease is very treatable, and that patients can go on to lead full lives.

Assessing Unique Patient Characteristics Critical in Deciding Therapy Options for Early Relapse Myeloma

March 18th 2021, 1:00pm

Article

An expert discusses the treatment options that patients with early relapse myeloma have to treat their recurrent disease, which often follows a cyclical pattern.

Educated Patient® Multiple Myeloma Summit: March 13, 2021

March 13th 2021, 3:00pm

Video

View the full CURE Educated Patient Multiple Myeloma Summit on demand.

Clinical Trials on Smoldering Myeloma May Open Doors to More Precision Medicine

December 29th 2020, 10:00pm

Article

In an interview with CURE®, Dr. Irene M. Ghobrial discussed smoldering myeloma, a precursor condition that may progress to multiple myeloma, how to proceed if diagnosed with the condition and the available opportunities to participate in clinical trials to learn more.

Accurate Diagnosis, Staging Improves Myeloma Outcomes

December 16th 2020, 7:00pm

Article

Advancements in the diagnosis and staging of multiple myeloma continue to shape treatment decisions and improve outcomes.

A Beginner’s Guide to Understanding Myeloma

December 16th 2020, 4:00pm

Article

In an interview with CURE®, Dr. Giada Bianchi provides patients an overview of myeloma, including symptoms and risk factors of the disease people should look out for.

Understanding New Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

December 15th 2020, 10:15pm

Article

The complexity of multiple myeloma can make it difficult to treat, but with complexity comes more avenues for researchers to explore what treatments work best. Recently, CURE® spoke with an expert from Dana-Farber Cancer Institute on what patients can expect to see from the clinical setting.

Educated Patient Multiple Myeloma Summit On-Demand: Nov. 21, 2020

December 8th 2020, 4:30pm

Video

View the full CURE®Educated Patient® Multiple Myeloma Summit here!

Evolving Standards and Heated Debates in the Treatment of Newly Diagnosed Multiple Myeloma

December 4th 2020, 2:00pm

Article

Evolving standards of care in newly diagnosed multiple myeloma (MM) have given patients a wider variety of possibilities but can also be disconcerting. In a presentation during CURE®’s Educated Patient® Multiple Myeloma Summit, Dr. Clifton Mo, of Dana-Farber Cancer Institute, explores the treatment landscape and breaks down what these different options can offer patients.

Understanding the Key Aspects of a Multiple Myeloma Diagnosis

January 3rd 2020, 3:00am

Article

A multiple myeloma expert helps newly diagnosed patients understand the standard of care for their disease.